|
Jul 28
|
Sanofi’s Sarclisa gains EC approval for multiple myeloma treatment
|
|
Jul 25
|
Thermo Fisher Scientific (TMO) Unveils New Microscopes At M&M Conference
|
|
Jul 25
|
Stocks to watch next week: Microsoft, Apple, Shell, AstraZeneca and HSBC
|
|
Jul 25
|
Weekly Recap: 12 Health Press Releases You Need to See
|
|
Jul 25
|
Press Release: Sanofi’s Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma
|
|
Jul 24
|
C3.ai Expands Beyond Oil: Is Diversification Paying Off?
|
|
Jul 24
|
Kling Bio and Sanofi link for antibodies and epitopes discovery
|
|
Jul 24
|
Kling Bio Announces Collaboration with Sanofi for Accelerated Discovery of Neutralizing Antibodies
|
|
Jul 23
|
Africa Pharmaceuticals Market Analysis, Growth Trends, and Forecast Report 2025-2032 | Urbanization and NCDs Drive Demand, Regulatory Harmonization & Local Production Boost Growth
|
|
Jul 23
|
European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
|
|
Jul 23
|
Sanofi to acquire Vicebio’s share capital for $1.15bn upfront
|
|
Jul 23
|
Peptic Ulcer Drugs Market Forecast Report 2025-2034 | FDA Approves New Helicobacter pylori Treatment; Market Growth Expected
|
|
Jul 22
|
Sanofi Expands Respiratory Vaccine Portfolio With UK Biotech Buy
|
|
Jul 22
|
BEYFORTUS® reduced hospital and doctor visits for RSV disease in babies by 87%, according to largest US real-world study
|
|
Jul 22
|
Sanofi to acquire vaccine biotech in billion-dollar deal
|
|
Jul 22
|
Sanofi to Buy Vaccine Developer Vicebio for Up to $1.6 Billion
|
|
Jul 22
|
Billion euro deal: Sanofi buys UK biotech company to expand respiratory vaccine portfolio
|
|
Jul 22
|
Sanofi to Acquire UK Biotech Vicebio for $1.15 Billion to Bolster Respiratory Vaccine Pipeline
|
|
Jul 22
|
Vicebio, next-generation vaccine biotech, to be acquired by Sanofi for US$1.6 billion
|
|
Jul 22
|
Press Release: Sanofi to acquire Vicebio, expanding respiratory vaccines pipeline
|